 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analyst Evan Seigerman of BMO Capital reiterated a Buy rating on Terns Pharmaceuticals (TERN Research Report), with a price target of $18.00. Eva...

Optimistic Outlook for Terns Pharmaceuticals Amidst Favorable GLP-1 Agonist Market Dynamics

This is a signal that TERN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Terns Pharmaceuticals (TERN, $5.22) RSI Indicator left the overbought zone on December 01, 2023

FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ( Terns or the Company ) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN  Get Free Report) have been assigned a consensus rating of Moderate Buy from the nine analysts that are currently covering the...

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Brokerages

FOSTER CITY, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ( Terns or the Company ) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer

For the last three days, A.I.dvisor has detected that TERN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Terns Pharmaceuticals (TERN, $3.77) Aroon Indicator entered a Downtrend on November 21, 2023.

Terns Pharmaceuticals (TERN, $3.74) Aroon Indicator entered a Downtrend on November 20, 2023.

Terns Pharmaceuticals (TERN, $3.71) Aroon Indicator entered a Downtrend on November 17, 2023.

Terns Pharmaceuticals (TERN, $3.64) Aroon Indicator entered a Downtrend on November 16, 2023.

Terns Pharmaceuticals (TERN, $3.85) Aroon Indicator entered a Downtrend on November 15, 2023.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Market Cap	$417.73M
Volume (M)	262,175.00
52-Wk High	$14.04
52-Wk Low	$3.26

TERN Terns Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals